Clinical case report on the appearance of a withdrawal syndrome after interruption of a treatment with selective serotonin reuptake inhibitors (SSRIs);Syndrome de sevrage aux inhibiteurs selectifs de la recapture de la serotonine: A propos d'un cas

Praxis

Volumn 87, Issue 10, 1998, Pages 345-348

  Bryois, C ^a   Rubin, Ch ^a   Zbinden, J D ^b   Baumann, P ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^b Psychiat Psychotherapeute FMH   (Switzerland)

Author keywords

Citalopram; Fluoxetine; Fluvoxamine; Paroxetine; Selective serotonin reuptake inhibitors; Sertraline; SSRIs; Withdrawal syndrome

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DIBENZEPIN; FLUOXETINE; FLUVOXAMINE; MOCLOBEMIDE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MENTAL DISEASE; NEUROLOGIC DISEASE; SEROTONINERGIC SYSTEM; SOCIAL PHOBIA; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; FEMALE; HUMANS; NEUROLOGIC EXAMINATION; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032481670     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Noyes R. Jr., Garvey M.J., Cook B.I. et al.: Benzodiazepine withdrawal: a review of the evidence. J Clin Psychiatry; 49: 382-389, 1988.
2. Brown G., Stancer H.C., Moldofsky H. et al.: Withdrawal from long term high-dose despiramine therapy: Clincial and biological changes. Arch Gen Psychiat; 35: 1261-1264, 1978.
3. Gualtieri C.T., Staye J.: Whithdrawal symptoms after abrupt cessation of amitriptyline in an ligth-year-old hoy. Am J Psychiat: 136: 457-458, 1979.
4. Kramer J.C., Klein D.F., Fink M.: Withdrawal symptoms following discontinuation of imipramine therapy. Am J Psychiatry; 118: 549-550, 1961.
5. Mirin S., Schatzberg A.F., Creasey D.E.: Hypomania and mania after withdrawal of tricyclic antidepressant. Am J Psychial; 138, 87-89, 1981.
6. Santos A.B. Jr., McCurdy L.: Delirium after abrupt withdrawal from doxepin: Case report. Am J Psychiat; 137: 239-240, 1980.
7. Sathananthan G.L., Gershon S.: Imipramine withdrawal: An akatisia like syndrome. Am J Psychiat; 130: 1286-1287, 1973.
8. Shatan C.: Withdrawal symptoms after abrupt terminaison of imipramine Can. Psychiat. Assoc. J.: 11 (suppl.): S150-S158, 1966.
9. Stern S. L., Mendels J.: Withdrawal symptoms during the course of imipramine therapy. J Clin Psychiatry; 41: 66-67, 1980.
10. Dilsaver S.C.: Antidepressant withdrawal syndromes: phenomenology and pathology, Acta Psychiatry Scand; 79: 113-117, 1989.
11. Price J.S., Waller P.C., Wood S.M., Mackay A.: A comparison of the post-marketing safety of four selective serotonin re-uptake inhihitors including the investigation of symptoms occuring on withdrawal. Br J Clin Pharmacol; 42: 757-763, 1996.
12. Young A. H., Ashton C.H.: Pharmacokinetics of fluoxétine. Ti PS 17: 400, 1996.
13. Ellison J.M.: SSRI withdrawal buzz. J Clin Psychiatry: 55: 12: 544-545, 1994.
14. Mallya G., White K., Gunderson C.: Is there a serotoninergic withdrawal syndrome? Biol Psychiatry; 33: 851-852, 1993.
15. Frost L., Lal S.: Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors. Am J Psychiatry; 152: 5: 810, 1995.
16. Louie A.K., Lannon R.A., Ajari L.J.: Withdrawal reaction after sertraline discontinuation. Am J Psychiatry; 151: 3: 450-451, 1994.
17. Einbinder E.: Fluoxetine withdrawal? Am J Psychiatry; 152: 8: 1235, 1995.
18. Stoukides J.A., Stoukides C.A.: Extrapyramidal symptoms upon discontinuation of fluoxetine. Am J Psychiatry; 148: 9: 1263, 1991.
19. Debattista C., Schatzberg A.F.: Physical symptoms associated with paroxetine withdrawal. Am J Psychiatry; 152: 8: 1235-1236, 1995.
20. Bloch M., Stager S.V., Braun A.R., Rubinow D. R.: Severe psychiatric symptoms associated with paroxetine withdrawal. The Lancet; 346: 57, 1995.
21. Keuthen N.J., Cyr P., Ricciardi J.A., Minichiello W.E., Buttolph M.L., Jenike M.A.: Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine. J Clin Psychopahrmacol; 14/3: 206-207, 1994.
22. Pyke R.E.: Paroxetine withdrawal syndrome. Am J Psychiatry; 152: 1: 149-150, 1995.
23. Barr L.C., Goodman W.K., Price L.H.: Physical symptoms associated with paroxetine discontinuation. Am J Psychiatry; 151: 2; 289, 1994.
24. Phillips S.D.: A possible paroxetine withdrawal syndrome. Am J Psychiatry; 152: 4: 645-646, 1995.
25. Black D.W., Wesner R., Gabel J.: The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Pschiatry; 54: 4: 146-149, 1993.
26. Fava G.A., Grandi S.: Withdrawal syndromes after paroxetine and sertraline discontinuation. J Clin Psychopharmacol; 15/5: 374-375, 1995.
27. Coupland N., Bell C., Potokar J.: Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol; 16: 356-362, 1996.
28. Hyttel J.: Pharmacological characterization of selective scrotonin reuptake inhibitors (SSRI). Int Clin Psychopharmacology; 9 suppl 1: 19-26, 1994.
29. Boyer W.F., Feighner J.P.: Pharmacokinetics and drug interactions. In: Selective Serotonin Re-Uptake Inhibitors, Feighner J.P. and Boyer W.F. (Eds), John Wiley, Chichester; 81-88, 1991.
30. Johnson A.M.: The comparative pharmacological properties of selective serotonin reuptake inhibitors in animals, in selective Serotonin Re-Uptake Inhibitors. Feigner J.R. and Boyer W.F. (Eds), John Wiley, Chichester 1991.
31. Blier P., Chaput Y., de Montigny C.: Long term 5 HT reuptake blockade, but not monoamine oxydase inhibition, decrease the function of terminal 5 HT autoreceptors:an electrophysiological study in the rat brain. Naunyn Schmiedebergs. Arch Pharmacol; 337: 246-254, 1988.
32. Lejoyeux M., Ades J., Rouillon F.: Serotonin syndrome: Incidence, symptoms and treatment. CNS Drugs: 2 (2): 132-143, 1994.
33. Sternbach H.: The Serotonin syndrome. Am J Psychiatry: 148: 705-713, 1991.